JP Stock MarketDetailed Quotes

4578 Otsuka Holdings

Watchlist
  • 8091.0
  • +85.0+1.06%
20min DelayNoon Break Jan 27 11:30 JST
4.47TMarket Cap36.10P/E (Static)

Otsuka Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
16.86%621.15B
18.07%589.41B
15.87%519.52B
16.14%2.02T
14.33%539.49B
17.65%531.54B
15.02%499.19B
17.89%448.34B
16.00%1.74T
20.73%471.88B
Cost of revenue
5.74%166.53B
8.82%164.41B
10.99%151.8B
7.33%611.22B
16.41%165.87B
3.12%157.49B
2.12%151.09B
8.26%136.78B
15.04%569.5B
4.49%142.49B
Gross profit
21.54%454.62B
22.09%425B
18.02%367.72B
20.44%1.41T
13.43%373.62B
25.07%374.05B
21.69%348.11B
22.68%311.57B
16.47%1.17T
29.43%329.39B
Operating expense
12.12%315.29B
10.53%297.98B
17.79%282.96B
13.56%1.12T
13.84%324.65B
14.31%281.21B
12.56%269.6B
13.45%240.22B
15.47%982.43B
11.15%285.18B
Selling and administrative expenses
18.04%241.33B
21.98%239.97B
21.75%213.75B
11.49%807.36B
14.86%230.63B
11.15%204.45B
6.39%196.73B
13.63%175.56B
16.36%724.13B
9.53%200.79B
-General and administrative expense
18.04%241.33B
21.98%239.97B
21.75%213.75B
11.49%807.36B
14.86%230.63B
11.15%204.45B
6.39%196.73B
13.63%175.56B
16.36%724.13B
9.53%200.79B
Research and development costs
3.62%76.2B
-3.47%71.56B
6.50%72.39B
11.84%307.8B
13.14%92.17B
7.26%73.53B
12.56%74.13B
14.53%67.97B
18.48%275.23B
16.75%81.47B
Other operating expenses
-83.47%771M
-51.18%228M
-21.75%421M
-4.11%6.25B
-38.80%3.4B
943.18%4.66B
74.25%467M
119.59%538M
-13.08%6.52B
30.85%5.56B
Total other operating income
110.64%3.01B
696.13%13.78B
-6.39%3.6B
-75.56%5.73B
-41.44%1.54B
-79.37%1.43B
-84.99%1.73B
63.19%3.85B
106.60%23.45B
238.87%2.63B
Operating profit
50.08%139.33B
61.79%127.02B
18.79%84.76B
56.76%291.67B
10.76%48.97B
74.94%92.84B
68.67%78.51B
68.94%71.35B
22.03%186.06B
2,236.93%44.21B
Net non-operating interest income (expenses)
-967.33%-20.95B
38.37%7.86B
227.16%8.06B
-86.55%3.04B
11.81%-7.52B
-56.16%2.42B
-63.14%5.68B
-75.94%2.46B
147.57%22.63B
-984.84%-8.52B
Non-operating interest income
-400.52%-12.06B
52.71%10.49B
159.84%10.09B
-66.66%9.57B
23.12%-4.99B
-42.86%4.01B
-59.66%6.87B
-65.54%3.88B
105.23%28.69B
-321.68%-6.48B
Non-operating interest expense
456.07%8.89B
121.19%2.63B
43.14%2.03B
7.59%6.52B
24.20%2.53B
5.55%1.6B
-26.47%1.19B
37.16%1.42B
25.27%6.06B
3.82%2.04B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
52.63%11.24B
171.60%11.19B
30.98%7.39B
252.34%20.37B
55.47%3.24B
655.38%7.37B
1,004.29%4.12B
140.41%5.64B
-32.06%5.78B
1,632.35%2.08B
Special income (charges)
44.06%-15.8B
-261.97%-103.95B
40.76%-125M
-315.26%-172.42B
-964.74%-115.25B
-345.46%-28.24B
-5,380.53%-28.72B
99.11%-211M
-540.86%-41.52B
-657.98%-10.82B
Less:Write off
-44.06%15.8B
261.97%103.95B
-40.76%125M
315.26%172.42B
964.74%115.25B
345.46%28.24B
5,380.53%28.72B
-99.11%211M
540.86%41.52B
657.98%10.82B
Other non-operating income (expenses)
Income before tax
53.04%113.82B
-29.32%42.12B
26.30%100.08B
-17.52%142.66B
-361.74%-70.55B
39.77%74.37B
-3.58%59.59B
155.74%79.24B
5.69%172.95B
1,109.55%26.96B
Income tax
108.68%29.46B
-39.59%10.39B
27.76%21.18B
-51.91%17.16B
-947.97%-30.74B
30.93%14.12B
18.94%17.2B
143.59%16.58B
3.61%35.67B
296.37%3.63B
Net income
40.00%84.36B
-25.16%31.73B
25.91%78.9B
-8.58%125.5B
-270.66%-39.81B
42.02%60.26B
-10.46%42.4B
159.17%62.66B
6.25%137.28B
2,931.31%23.33B
Net income continuous operations
40.00%84.36B
-25.16%31.73B
25.91%78.9B
-8.58%125.5B
-270.66%-39.81B
42.02%60.26B
-10.46%42.4B
159.16%62.66B
6.25%137.28B
2,931.31%23.33B
Noncontrolling interests
-57.66%481M
6.42%1.31B
23.21%1.52B
15.12%3.88B
-38.34%283M
-2.07%1.14B
49.21%1.23B
32.76%1.23B
-9.93%3.37B
27.15%459M
Net income attributable to the company
41.88%83.88B
-26.10%30.42B
25.96%77.38B
-9.18%121.62B
-275.33%-40.1B
43.26%59.12B
-11.52%41.16B
164.22%61.43B
6.73%133.91B
2,029.96%22.87B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
41.88%83.88B
-26.10%30.42B
25.96%77.38B
-9.18%121.62B
-275.33%-40.1B
43.26%59.12B
-11.52%41.16B
164.22%61.43B
6.73%133.91B
2,029.96%22.87B
Gross dividend payment
Basic earnings per share
42.04%154.72
-26.13%56.03
25.96%142.59
-9.20%224.1
-275.34%-73.89
43.25%108.93
-11.53%75.85
164.12%113.2
6.69%246.8
2,033.03%42.14
Diluted earnings per share
42.04%154.72
-26.13%56.03
25.99%142.59
-9.19%224.1
-275.34%-73.89
43.29%108.93
-11.48%75.85
165.06%113.18
6.76%246.78
2,024.20%42.14
Dividend per share
0
20.00%60
0
10.00%110
20.00%60
0
0.00%50
0
0.00%100
0.00%50
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 16.86%621.15B 18.07%589.41B 15.87%519.52B 16.14%2.02T 14.33%539.49B 17.65%531.54B 15.02%499.19B 17.89%448.34B 16.00%1.74T 20.73%471.88B
Cost of revenue 5.74%166.53B 8.82%164.41B 10.99%151.8B 7.33%611.22B 16.41%165.87B 3.12%157.49B 2.12%151.09B 8.26%136.78B 15.04%569.5B 4.49%142.49B
Gross profit 21.54%454.62B 22.09%425B 18.02%367.72B 20.44%1.41T 13.43%373.62B 25.07%374.05B 21.69%348.11B 22.68%311.57B 16.47%1.17T 29.43%329.39B
Operating expense 12.12%315.29B 10.53%297.98B 17.79%282.96B 13.56%1.12T 13.84%324.65B 14.31%281.21B 12.56%269.6B 13.45%240.22B 15.47%982.43B 11.15%285.18B
Selling and administrative expenses 18.04%241.33B 21.98%239.97B 21.75%213.75B 11.49%807.36B 14.86%230.63B 11.15%204.45B 6.39%196.73B 13.63%175.56B 16.36%724.13B 9.53%200.79B
-General and administrative expense 18.04%241.33B 21.98%239.97B 21.75%213.75B 11.49%807.36B 14.86%230.63B 11.15%204.45B 6.39%196.73B 13.63%175.56B 16.36%724.13B 9.53%200.79B
Research and development costs 3.62%76.2B -3.47%71.56B 6.50%72.39B 11.84%307.8B 13.14%92.17B 7.26%73.53B 12.56%74.13B 14.53%67.97B 18.48%275.23B 16.75%81.47B
Other operating expenses -83.47%771M -51.18%228M -21.75%421M -4.11%6.25B -38.80%3.4B 943.18%4.66B 74.25%467M 119.59%538M -13.08%6.52B 30.85%5.56B
Total other operating income 110.64%3.01B 696.13%13.78B -6.39%3.6B -75.56%5.73B -41.44%1.54B -79.37%1.43B -84.99%1.73B 63.19%3.85B 106.60%23.45B 238.87%2.63B
Operating profit 50.08%139.33B 61.79%127.02B 18.79%84.76B 56.76%291.67B 10.76%48.97B 74.94%92.84B 68.67%78.51B 68.94%71.35B 22.03%186.06B 2,236.93%44.21B
Net non-operating interest income (expenses) -967.33%-20.95B 38.37%7.86B 227.16%8.06B -86.55%3.04B 11.81%-7.52B -56.16%2.42B -63.14%5.68B -75.94%2.46B 147.57%22.63B -984.84%-8.52B
Non-operating interest income -400.52%-12.06B 52.71%10.49B 159.84%10.09B -66.66%9.57B 23.12%-4.99B -42.86%4.01B -59.66%6.87B -65.54%3.88B 105.23%28.69B -321.68%-6.48B
Non-operating interest expense 456.07%8.89B 121.19%2.63B 43.14%2.03B 7.59%6.52B 24.20%2.53B 5.55%1.6B -26.47%1.19B 37.16%1.42B 25.27%6.06B 3.82%2.04B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests 52.63%11.24B 171.60%11.19B 30.98%7.39B 252.34%20.37B 55.47%3.24B 655.38%7.37B 1,004.29%4.12B 140.41%5.64B -32.06%5.78B 1,632.35%2.08B
Special income (charges) 44.06%-15.8B -261.97%-103.95B 40.76%-125M -315.26%-172.42B -964.74%-115.25B -345.46%-28.24B -5,380.53%-28.72B 99.11%-211M -540.86%-41.52B -657.98%-10.82B
Less:Write off -44.06%15.8B 261.97%103.95B -40.76%125M 315.26%172.42B 964.74%115.25B 345.46%28.24B 5,380.53%28.72B -99.11%211M 540.86%41.52B 657.98%10.82B
Other non-operating income (expenses)
Income before tax 53.04%113.82B -29.32%42.12B 26.30%100.08B -17.52%142.66B -361.74%-70.55B 39.77%74.37B -3.58%59.59B 155.74%79.24B 5.69%172.95B 1,109.55%26.96B
Income tax 108.68%29.46B -39.59%10.39B 27.76%21.18B -51.91%17.16B -947.97%-30.74B 30.93%14.12B 18.94%17.2B 143.59%16.58B 3.61%35.67B 296.37%3.63B
Net income 40.00%84.36B -25.16%31.73B 25.91%78.9B -8.58%125.5B -270.66%-39.81B 42.02%60.26B -10.46%42.4B 159.17%62.66B 6.25%137.28B 2,931.31%23.33B
Net income continuous operations 40.00%84.36B -25.16%31.73B 25.91%78.9B -8.58%125.5B -270.66%-39.81B 42.02%60.26B -10.46%42.4B 159.16%62.66B 6.25%137.28B 2,931.31%23.33B
Noncontrolling interests -57.66%481M 6.42%1.31B 23.21%1.52B 15.12%3.88B -38.34%283M -2.07%1.14B 49.21%1.23B 32.76%1.23B -9.93%3.37B 27.15%459M
Net income attributable to the company 41.88%83.88B -26.10%30.42B 25.96%77.38B -9.18%121.62B -275.33%-40.1B 43.26%59.12B -11.52%41.16B 164.22%61.43B 6.73%133.91B 2,029.96%22.87B
Preferred stock dividends
Other under preferred stock dividend 0 0 0 0 0 0 0 0 0 0
Net income attributable to common stockholders 41.88%83.88B -26.10%30.42B 25.96%77.38B -9.18%121.62B -275.33%-40.1B 43.26%59.12B -11.52%41.16B 164.22%61.43B 6.73%133.91B 2,029.96%22.87B
Gross dividend payment
Basic earnings per share 42.04%154.72 -26.13%56.03 25.96%142.59 -9.20%224.1 -275.34%-73.89 43.25%108.93 -11.53%75.85 164.12%113.2 6.69%246.8 2,033.03%42.14
Diluted earnings per share 42.04%154.72 -26.13%56.03 25.99%142.59 -9.19%224.1 -275.34%-73.89 43.29%108.93 -11.48%75.85 165.06%113.18 6.76%246.78 2,024.20%42.14
Dividend per share 0 20.00%60 0 10.00%110 20.00%60 0 0.00%50 0 0.00%100 0.00%50
Currency Unit JPY JPY JPY JPY JPY JPY JPY JPY JPY JPY
Accounting Standards NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Nyle
5618
358 +28.78%
CellSeed
7776
449 +20.05%
Soiken Holdings
2385
197 +16.57%
Renascience
4889
1207 +16.06%
Elements
5246
751 +15.36%

See the daily top gainer.